Sun Pharmaceutical Industries
₹1,810.00
At a glance
- Revenue growth
- +11.19%
- FY to Mar 2026 vs FY to Mar 2025
- Net income growth
- +5.04%
- FY to Mar 2026 vs FY to Mar 2025
- Net margin
- 19.6%
- FY to Mar 2025: 20.8%
Financial data
Amounts in millions of INR; per-share values in INR; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 152,999 | 146,118 | 155,205 | 144,783 | 138,514 | 129,588 | 136,755 | 132,914 | 126,528 | 119,829 | 123,807 | 121,924 |
| Cost of revenue | 29,632 | 37,361 | 29,451 | 29,827 | 28,148 | 34,483 | 27,405 | 26,942 | 26,754 | 31,600 | 27,369 | 27,871 |
| Gross profit | 123,367 | 108,757 | 125,754 | 114,956 | 110,366 | 95,106 | 109,349 | 105,972 | 99,773 | 88,229 | 96,438 | 94,053 |
| Selling, general and administrative | 32,272 | 30,598 | 28,920 | 27,648 | 28,017 | 25,663 | 25,523 | 24,777 | 24,546 | 23,728 | 23,633 | 23,644 |
| Operating income | 35,570 | 28,102 | 40,622 | 33,671 | 33,721 | 28,558 | 35,618 | 31,850 | 30,029 | 25,310 | 27,301 | 25,807 |
| EBIT | 35,570 | 28,102 | 40,622 | 33,671 | 33,721 | 28,558 | 35,618 | 31,850 | 30,029 | 25,310 | 27,301 | 25,807 |
| EBITDA | 42,324 | 34,857 | 46,529 | 40,821 | 39,627 | 34,464 | 41,508 | 38,255 | 35,919 | 31,199 | 33,165 | 32,227 |
| Interest expense | 997 | 859 | 784 | 999 | 748 | 491 | 515 | 692 | 615 | 736 | 347 | 493 |
| Pre-tax income | 40,892 | 35,373 | 42,072 | 41,555 | 31,630 | 32,476 | 34,718 | 36,045 | 34,128 | 28,077 | 29,929 | 27,752 |
| Income tax | 11,880 | 8,276 | 8,261 | 10,305 | 8,702 | 10,937 | 5,589 | 5,672 | 5,523 | 1,489 | 4,323 | 3,901 |
| Net income | 28,948 | 27,140 | 33,688 | 31,180 | 22,786 | 21,499 | 29,034 | 30,402 | 28,356 | 26,546 | 25,238 | 23,755 |
| Net income to common shareholders | 28,948 | 27,140 | 33,688 | 31,180 | 22,786 | 21,499 | 29,034 | 30,402 | 28,356 | 26,546 | 25,238 | 23,755 |
| Basic EPS | 12.10 | 11.30 | 14.00 | 13.00 | 9.50 | 9.00 | 12.10 | 12.70 | 11.80 | 11.10 | 10.50 | 9.90 |
| Diluted EPS | 12.10 | 11.26 | 14.00 | 13.00 | 9.50 | 9.00 | 12.10 | 12.70 | 11.80 | 11.09 | 10.50 | 9.90 |
| Average shares (basic) | 2,392 | 2,402 | 2,406 | 2,398 | 2,399 | 2,389 | 2,399 | 2,394 | 2,403 | 2,392 | 2,404 | 2,400 |
| Average shares (diluted) | 2,392 | 2,402 | 2,406 | 2,398 | 2,399 | 2,389 | 2,399 | 2,394 | 2,403 | 2,392 | 2,404 | 2,400 |
| Dividend per share | — | 5.00 | 11.00 | — | — | 5.50 | 10.50 | — | — | 5.00 | 8.50 | — |
